What are analysts' expectations for UnitedHealth's Q2 earnings?

Analysts expect Q2 revenue between $98 billion and $100 billion, with EPS around $6.80.

How has UNH stock performed ahead of earnings?

UNH stock has declined about 8% year-to-date due to regulatory concerns and rising medical costs.

Should You Buy UnitedHealth Group Stock Before July 16?

UnitedHealth Group (UNH) is set to report its second-quarter results on July 16. This article discusses whether investors should buy the stock before the earnings announcement.

June 29, 2026

2 min read

Source: Motley Fool

UnitedHealth Group (UNH), the US healthcare giant, is scheduled to release its second-quarter fiscal 2026 results on July 16. The announcement comes as investors watch for the company's performance amid regulatory challenges and cost pressures.

Announcement Details

UnitedHealth will report Q2 results after market close on July 16, 2026. No preliminary guidance has been issued, but analysts expect revenue between $98 billion and $100 billion, with EPS around $6.80.

Context

UNH stock has been volatile this year, down about 8% year-to-date due to concerns over tighter regulation of the health insurance sector and rising medical costs. Nonetheless, the company remains the largest US health insurer by revenue.

What This Means for Investors

The upcoming earnings release offers a chance to assess the company's performance in a challenging economic environment. Investors are looking for signs of revenue growth and cost control. Waraqaty does not offer buy or sell recommendations; it advises monitoring results and making decisions based on personal analysis.

Frequently Asked Questions

UnitedHealth Group (UNH) will report its second-quarter fiscal 2026 results on July 16, 2026 after market close.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.